Study of a device to close the groin artery after heart or blood vessel procedures
This study tests a new device that seals the small hole in the groin artery after procedures like TAVI or EVAR. It aims to stop bleeding quickly and safely, helping you recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are having a planned (not emergency) procedure that uses a large tube in the groin artery, such as TAVI or EVAR.
- Your groin artery is at least 6 mm wide, as checked by a CT scan before the procedure.
- You are willing and able to have emergency surgery if needed.
- You can understand and sign the study consent form and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device that helps close the puncture site in your leg after certain heart or blood vessel procedures. It aims to reduce bleeding and speed up recovery.
This study tests a new device that closes the large hole in the groin after certain heart or blood vessel procedures. It may help people who need a large tube (catheter) in their leg during these procedures.
This trial tests a device that helps close the puncture hole in your leg vein after a heart procedure, which may reduce bleeding and help you recover faster.
This trial tests if patients can safely walk sooner after a leg artery procedure when a special closure device (ProGlide) is used. It aims to find the best time to get up and move, which could mean faster recovery.
This trial tests a new device called xDot that helps close the small hole in the leg after a heart procedure like a valve replacement or aneurysm repair. It is a feasibility study, meaning the device is being tested for safety and how well it works in people.
This study compares two ways of closing the large artery in the groin after a TAVI procedure (a minimally invasive heart valve replacement). It aims to see which method is safer and more effective, which could help reduce bleeding and other complications.
Hear when a new Vascular Closure Device trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.